Literature DB >> 8448286

Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts.

D M Tritz1, G L Woods.   

Abstract

Aspergillus terreus is widespread in the environment but only uncommonly infects humans. It can cause cutaneous and subcutaneous infections, and several cases of local invasive disease have been reported; to our knowledge, however, only five cases of disseminated disease have been documented previously. We describe here four additional patients with disseminated disease caused by A. terreus. All four had an underlying hematologic or lymphoreticular malignancy, were immunocompromised secondary to prolonged neutropenia or immunosuppressive therapy, and had invasive pulmonary disease (a circumstance supporting a respiratory route of infection). Despite treatment with amphotericin B, all four patients died. When recovered from clinical specimens, A. terreus should not routinely be dismissed as a saprobe, particularly in immunocompromised hosts.

Entities:  

Mesh:

Year:  1993        PMID: 8448286     DOI: 10.1093/clinids/16.1.118

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.

Authors:  Cornelia Lass-Flörl; Alexandra Rief; Sandra Leitner; Cornelia Speth; Reinhard Würzner; Manfred P Dierich
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus.

Authors:  Z U Khan; M Kortom; R Marouf; R Chandy; M G Rinaldi; D A Sutton
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.

Authors:  C Lass-Flörl; M Nagl; C Speth; H Ulmer; M P Dierich; R Würzner
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  Epidemiology of Aspergillus terreus at a university hospital.

Authors:  John W Baddley; Peter G Pappas; Anita C Smith; Stephen A Moser
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture.

Authors:  G Schett; B Casati; B Willinger; G Weinländer; T Binder; F Grabenwöger; W Sperr; K Geissler; U Jäger
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Fungal endocarditis presenting with right lumbar pain and femoral artery ischemia - An unusual case report.

Authors:  Shahan Waheed; Muhammad Akbar Baig; Muhammad Waqas Khan; Fareed Ahmed Sheikh; Nadeem Ullah Khan
Journal:  Turk J Emerg Med       Date:  2016-04-15

9.  Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.

Authors:  Célia F Rodrigues; Mariana Henriques
Journal:  Pathogens       Date:  2017-12-01

Review 10.  Candida glabrata Biofilms: How Far Have We Come?

Authors:  Célia F Rodrigues; Maria Elisa Rodrigues; Sónia Silva; Mariana Henriques
Journal:  J Fungi (Basel)       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.